A new FIFA 21 update is available for download. On April 5, EA Sports released Update 1.18, which mainly addresses connection problems and puts a new data center in Buenos Aires into operation.
FIFRA section 2(ee) bulletins are recommendations, allowed by section 2(ee)(2) of FIFRA, advocating use of a product on a pest not specified on the labeling if the pest is on a site listed on the label and the agency has not required labeling that only allows use on specified pests. FIFRA section 2(ee) bulletins may be distributed by virtually any means; i.e., through extension personnel, industry representatives, at the point of sale, displayed with the product, or downloaded off the Internet, provided the bulletin is factually correct and conforms to the restrictions of section 2 (ee). EPA does not allow 2(ee) bulletins for antimicrobial products with public health claims (i.e., targeted against human pathogens, 40 CFR 168.22(b) (5)) or other products with such claims. FIFRA section 2(ee) reads as follows:
EPA directs users to follow the use directions found on the label of the container and in any EPA-approved supplemental labeling of the pesticide they are applying that accompanies the pesticide. Labels acquired from web sites may not be the most current label or may conflict with the label on the container. Because the label on the container is the label that must be followed along with any EPA-approved supplemental labeling which must accompany the user at the time of application, users should not download entire section 3 labels for use.
Attaching supplemental labeling inappropriately, either by downloading supplemental labeling from a website or handing out hard copy supplemental labeling at the point of sale, could be unlawful if it violates the production establishment registration and reporting provisions of FIFRA Section 7 (see FIFRA 12(a)(2)(L)). Further, sale and distribution of product that is inappropriately accompanied by supplemental labeling could constitute sale and distribution of a misbranded pesticide or a product with claims that substantially differ from what has been approved, which are an unlawful acts under FIFRA 12(a)(1)(E) and FIFRA 12(a)(1)(B). 2b1af7f3a8